Lacticaseibacillus paracasei GM-080 Ameliorates Allergic Airway Inflammation in Children with Allergic Rhinitis: From an Animal Model to a Double-Blind, Randomized, Placebo-Controlled Trial

被引:17
作者
Lin, En-Kwang [1 ,2 ]
Chang, Wen-Wei [3 ,4 ]
Jhong, Jhih-Hua [5 ]
Tsai, Wan-Hua [6 ]
Chou, Chia-Hsuan [6 ]
Wang, I-Jen [7 ,8 ,9 ,10 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei 112304, Taiwan
[2] Taipei Med Univ, Wanfang Hosp, Dept Surg, Div Colorectal Surg, Taipei 110301, Taiwan
[3] Chung Shan Med Univ, Sch Biomed Sci, Taichung, Taiwan
[4] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[5] Hsinchu MacKay Mem Hosp, Dept Med Res, Hsinchu, Taiwan
[6] GenMont Biotech Inc, Res & Dev Dept, Tainan, Taiwan
[7] Taipei Hosp, Dept Pediat, Minist Hlth & Welf, New Taipei 242033, Taiwan
[8] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei 112304, Taiwan
[9] China Med Univ, Coll Publ Hlth, Taichung, Taiwan
[10] Taipei Hosp, Dept Pediat, Minist Hlth & Welf, 127 Su-Yuan Rd, Miaoli, Taiwan
关键词
allergic airway inflammation; animal model; allergic rhinitis; clinical trial; probiotics; MUCUS PRODUCTION; PROBIOTICS; GENOME; RESPONSES; HISTORY; MICE; DNA;
D O I
10.3390/cells12050768
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Probiotics may facilitate the clinical management of allergic diseases. However, their effects on allergic rhinitis (AR) remain unclear. We examined the efficacy and safety of Lacticaseibacillus paracasei GM-080 in a mouse model of airway hyper-responsiveness (AHR) and in children with perennial AR (PAR) by using a double-blind, prospective, randomized, placebo-controlled design. Methods: The production of interferon (IFN)-gamma and interleukin (IL)-12 was measured by using an enzyme-linked immunosorbent assay. GM-080 safety was evaluated via the whole-genome sequencing (WGS) of virulence genes. An ovalbumin (OVA)-induced AHR mouse model was constructed, and lung inflammation was evaluated by measuring the infiltrating leukocyte content of bronchoalveolar lavage fluid. A clinical trial was conducted with 122 children with PAR who were randomized to receive different doses of GM-080 or the placebo for 3 months, and their AHR symptom severity scores, total nasal symptom scores (TNSSs), and Investigator Global Assessment Scale scores were examined. Results: Among the tested L. paracasei strains, GM-080 induced the highest IFN-gamma and IL-12 levels in mouse splenocytes. WGS analysis revealed the absence of virulence factors or antibiotic-resistance genes in GM-080. The oral administration of GM-080 at 1 x 10(7) colony forming units (CFU)/mouse/day for 8 weeks alleviated OVA-induced AHR and reduced airway inflammation in mice. In children with PAR, the oral consumption of GM-080 at 2 x 10(9) CFU/day for 3 months ameliorated sneezing and improved Investigator Global Assessment Scale scores significantly. GM-080 consumption led to a nonsignificant decrease in TNSS and also nonsignificantly reduced IgE but increased INF-gamma levels. Conclusion: GM-080 may be used as a nutrient supplement to alleviate airway allergic inflammation.
引用
收藏
页数:19
相关论文
共 53 条
  • [1] Efficacy of probiotic in perennial allergic rhinitis under five year children: A randomized controlled trial
    Ahmed, Mubashir
    Billoo, Abdul Gaffar
    Iqbal, Khalid
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2019, 35 (06) : 1538 - 1543
  • [2] CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database
    Alcock, Brian P.
    Raphenya, Amogelang R.
    Lau, Tammy T. Y.
    Tsang, Kara K.
    Bouchard, Megane
    Edalatmand, Arman
    Huynh, William
    Nguyen, Anna-Lisa, V
    Cheng, Annie A.
    Liu, Sihan
    Min, Sally Y.
    Miroshnichenko, Anatoly
    Tran, Hiu-Ki
    Werfalli, Rafik E.
    Nasir, Jalees A.
    Oloni, Martins
    Speicher, David J.
    Florescu, Alexandra
    Singh, Bhavya
    Faltyn, Mateusz
    Hernandez-Koutoucheva, Anastasia
    Sharma, Arjun N.
    Bordeleau, Emily
    Pawlowski, Andrew C.
    Zubyk, Haley L.
    Dooley, Damion
    Griffiths, Emma
    Maguire, Finlay
    Winsor, Geoff L.
    Beiko, Robert G.
    Brinkman, Fiona S. L.
    Hsiao, William W. L.
    Domselaar, Gary, V
    McArthur, Andrew G.
    [J]. NUCLEIC ACIDS RESEARCH, 2020, 48 (D1) : D517 - D525
  • [3] Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
    Aponte, Maria
    Murru, Nicoletta
    Shoukat, Mahtab
    [J]. FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [4] Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance
    Aquilina, Gabriele
    Bories, Georges
    Chesson, Andrew
    Cocconcelli, Pier Sandro
    de Knecht, Joop
    Dierick, Noel Albert
    Gralak, Mikolaj Antoni
    Gropp, Jurgen
    Halle, Ingrid
    Hogstrand, Christer
    Leng, Lubomir
    Puente, Secundino Lopez
    Haldorsen, Anne-Katrine Lundebye
    Mantovani, Alberto
    Martelli, Giovanna
    Mezes, Miklos
    Renshaw, Derek
    Saarela, Maria
    Sejrsen, Kristen
    Westendorf, Johannes
    [J]. EFSA JOURNAL, 2012, 10 (06)
  • [5] ResFinder 4.0 for predictions of phenotypes from genotypes
    Bortolaia, Valeria
    Kaas, Rolf S.
    Ruppe, Etienne
    Roberts, Marilyn C.
    Schwarz, Stefan
    Cattoir, Vincent
    Philippon, Alain
    Allesoe, Rosa L.
    Rebelo, Ana Rita
    Florensa, Alfred Ferrer
    Fagelhauer, Linda
    Chakraborty, Trinad
    Neumann, Bernd
    Werner, Guido
    Bender, Jennifer K.
    Stingl, Kerstin
    Minh Nguyen
    Coppens, Jasmine
    Xavier, Basil Britto
    Malhotra-Kumar, Surbhi
    Westh, Henrik
    Pinholt, Mette
    Anjum, Muna F.
    Duggett, Nicholas A.
    Kempf, Isabelle
    Nykasenoja, Suvi
    Olkkola, Satu
    Wieczorek, Kinga
    Amaro, Ana
    Clemente, Lurdes
    Mossong, Joel
    Losch, Serge
    Ragimbeau, Catherine
    Lund, Ole
    Aarestrup, Frank M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (12) : 3491 - 3500
  • [6] Regulatory role of suppressive motifs from commensal DNA
    Bouladoux, N.
    Hall, J. A.
    Grainger, J. R.
    dos Santos, L. M.
    Kann, M. G.
    Nagarajan, V.
    Verthelyi, D.
    Belkaid, Y.
    [J]. MUCOSAL IMMUNOLOGY, 2012, 5 (06) : 623 - 634
  • [7] ATTENUATION OF ALLERGIC AIRWAY INFLAMMATION IN IL-4 DEFICIENT MICE
    BRUSSELLE, GG
    KIPS, JC
    TAVERNIER, JH
    VANDERHEYDEN, JG
    CUVELIER, CA
    PAUWELS, RA
    BLUETHMANN, H
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (01) : 73 - 80
  • [8] Cohn L, 1999, J IMMUNOL, V162, P6178
  • [9] Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production
    Cohn, L
    Homer, RJ
    Marinov, A
    Rankin, J
    Bottomly, K
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) : 1737 - 1747
  • [10] Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)
    Costal, D. J.
    Marteau, P.
    Amouyall, M.
    Poulsen, L. K.
    Hamelmann, E.
    Cazaubie, M., I
    Housez, B.
    Leuillet, S.
    Stavnsbjere, M.
    Molimard, P.
    Courau, S.
    Bousquet, J.
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2014, 68 (05) : 602 - 607